Functional expression of Francisella tularensis FabH and FabI, potential antibacterial targets von Wen, Lisa, Chmielowski, Jennifer N., Bohn, Kelsey C., Huang, Jenq-Kuen, Timsina, Yam N., Kodali, Phanichand, Pathak, Ashish K.

Volltext

Overexpression of recombinant human procathepsin D in E. coli von Keefer, Ryan, McConnell, Matthew, Ye, Alice, Chmielowski, Jennifer, Berryman, Laura, Wen, Lisa, McConnell, Rose

Volltext

Overexpression of recombinant human procathepsin B in E. coli von Wen, Lisa, Chmielowski, Jennifer, McConnell, Matthew, Hunter, Jessica, Keefer, Ryan, McConnell, Rose

Volltext

Expression and purification of active human recombinant cathepsin K in E. coli von Tha, Soe, McConnell, Matthew, Berryman, Laura, Chmielowski, Jennifer, Bordowitz, Michael, Liang, Kenneth, Lafollette, Jessica, Wen, Lisa, McConnell, Rose

Volltext

Expression and characterization of Francisella tularensis fatty acid biosynthetic genes FabD and FabH in E. coli von Chmielowski, Jennifer N, Bohn, Kelsey C, Wen, Lisa, Huang, Jenq‐Kuen, Timsina, Yam N, Chand, Phani C, Pathak, Ashish K

Volltext

Expression and characterization of active francisella tularensis FabI enzyme, a potential antibacterial target von Bohn, Kelsey C, Chmielowski, Jennifer N, Wen, Lisa, Huang, Jenq‐Kuen, Timsina, Yam N, Chand, Phani C, Pathak, Ashish K

Volltext

PD-1 blockade induces responses by inhibiting adaptive immune resistance von Tumeh, Paul C., Harview, Christina L., Yearley, Jennifer H., Shintaku, I. Peter, Taylor, Emma J. M., Robert, Lidia, Chmielowski, Bartosz, Spasic, Marko, Henry, Gina, Ciobanu, Voicu, West, Alisha N., Carmona, Manuel, Kivork, Christine, Seja, Elizabeth, Cherry, Grace, Gutierrez, Antonio J., Grogan, Tristan R., Mateus, Christine, Tomasic, Gorana, Glaspy, John A., Emerson, Ryan O., Robins, Harlan, Pierce, Robert H., Elashoff, David A., Robert, Caroline, Ribas, Antoni

Volltext

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma von Grasso, Catherine S., Tsoi, Jennifer, Onyshchenko, Mykola, Abril-Rodriguez, Gabriel, Ross-Macdonald, Petra, Wind-Rotolo, Megan, Champhekar, Ameya, Medina, Egmidio, Torrejon, Davis Y., Shin, Daniel Sanghoon, Tran, Phuong, Kim, Yeon Joo, Puig-Saus, Cristina, Campbell, Katie, Vega-Crespo, Agustin, Quist, Michael, Martignier, Christophe, Luke, Jason J., Wolchok, Jedd D., Johnson, Douglas B., Chmielowski, Bartosz, Hodi, F. Stephen, Bhatia, Shailender, Sharfman, William, Urba, Walter J., Slingluff, Craig L., Diab, Adi, Haanen, John B.A.G., Algarra, Salvador Martin, Pardoll, Drew M., Anagnostou, Valsamo, Topalian, Suzanne L., Velculescu, Victor E., Speiser, Daniel E., Kalbasi, Anusha, Ribas, Antoni

Volltext

A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab von Nowicki, Theodore S, Berent-Maoz, Beata, Cheung-Lau, Gardenia, Huang, Rong Rong, Wang, Xiaoyan, Tsoi, Jennifer, Kaplan-Lefko, Paula, Cabrera, Paula, Tran, Justin, Pang, Jia, Macabali, Mignonette, Garcilazo, Ivan Perez, Carretero, Ignacio Baselga, Kalbasi, Anusha, Cochran, Alistair J, Grasso, Catherine S, Hu-Lieskovan, Siwen, Chmielowski, Bartosz, Comin-Anduix, Begoña, Singh, Arun, Ribas, Antoni

Volltext

A phase 2 study of alrizomadlin (APG-115) in combination with pembrolizumab in patients with unresectable or metastatic cutaneous melanoma that has failed immuno-oncologic (IO) dru... von Shaheen, Montaser F., Segar, Jennifer Margaret, Chmielowski, Bartosz, Drabick, Joseph J., McKean, Meredith, Reeves, James A., Karapetis, Christos Stelios, Orloff, Marlana M., Tolcher, Anthony W., Beck, J. Thaddeus Thaddeus, Gastman, Brian, De, Asit, Paudyal, Ben, Winkler, Robert E, Li, Mingyu, Ahmad, Mohammad, Yang, Dajun, Zhai, Yifan

Volltext

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma von Grasso, Catherine S., Tsoi, Jennifer, Onyshchenko, Mykola, Abril-Rodriguez, Gabriel, Ross-Macdonald, Petra, Wind-Rotolo, Megan, Champhekar, Ameya, Medina, Egmidio, Torrejon, Davis Y., Shin, Daniel Sanghoon, Tran, Phuong, Kim, Yeon Joo, Puig-Saus, Cristina, Campbell, Katie, Vega-Crespo, Agustin, Quist, Michael, Martignier, Christophe, Luke, Jason J., Wolchok, Jedd D., Johnson, Douglas B., Chmielowski, Bartosz, Hodi, F. Stephen, Bhatia, Shailender, Sharfman, William, Urba, Walter J., Slingluff, Craig L., Diab, Adi, Haanen, John B.A.G., Algarra, Salvador Martin, Pardoll, Drew M., Anagnostou, Valsamo, Topalian, Suzanne L., Velculescu, Victor E., Speiser, Daniel E., Kalbasi, Anusha, Ribas, Antoni

Volltext

Phase 1b/2 study of olaratumab plus gemcitabine and docetaxel for the treatment of advanced soft tissue sarcoma (STS) (ANNOUNCE 2): Phase 1b results von Villalobos, Victor Manuel, Redondo, Andres, Van Tine, Brian Andrew, Schwartz, Gary K., Dickson, Mark Andrew, Chmielowski, Bartosz, Peterson, Patrick, Cronier, Damien, Wright, Jennifer A., Attia, Steven

Volltext

CRAF R391W is a melanoma driver oncogene von Atefi, Mohammad, Titz, Bjoern, Tsoi, Jennifer, Avramis, Earl, Le, Allison, Ng, Charles, Lomova, Anastasia, Lassen, Amanda, Friedman, Michael, Chmielowski, Bartosz, Ribas, Antoni, Graeber, Thomas G.

Volltext

434 Updated clinical data from the melanoma expansion cohort of an ongoing Ph1/1b Study of eganelisib (formerly IPI-549) in combination with nivolumab von Postow, Michael, Sullivan, Ryan, Cohen, Ezra, Gutierrez, Martin, Hong, David, Steuer, Conor, McCarter, Jerry, Zizlsperger, Nora, Kutok, Jeff, O’Connell, Brenda, Roberts, Jennifer, Page, Kara, Zhang, Halle, Chmielowski, Bartosz

Volltext

Initial results from first-in-human study of IPI-549, a tumor macrophage-targeting agent, combined with nivolumab in advanced solid tumors von Sullivan, Ryan J., Hong, David S., Tolcher, Anthony W., Patnaik, Amita, Shapiro, Geoffrey, Chmielowski, Bartosz, Ribas, Antoni, Brail, Les H., Roberts, Jennifer, Lee, Lucy, O'Connell, Brenda, Kutok, Jeffrey Lorne, Mahabhashyam, Suresh, Dansky Ullmann, Claudio, Postow, Michael A., Wolchok, Jedd D.

Volltext

352 Updated clinical data from the squamous cell carcinoma of the head and neck (SCCHN) expansion cohort of an ongoing Ph1/1b Study of eganelisib (formerly IPI-549) in combination... von Cohen, Ezra, Postow, Michael, Sullivan, Ryan, Hong, David, Yeckes-Rodin, Heather, McCarter, Jerry, Zizlsperger, Nora, Kutok, Jeffery, Brenda O’Connell, Page, Kara, Roberts, Jennifer, Zhang, Halle, Chmielowski, Bartosz

Volltext

PROCESSES FOR ISOLATION AND PURIFICATION OF ENFUMAFUNGIN von CHMIELOWSKI, Rebecca, A, POLLARD, Jennifer, M, DEITRICH, Lisa, M, GAILLIOT, Francis, P, GOKLEN, Kent

Volltext bestellen

Procedimientos para el aislamiento y purificación de enfumafungina von CHMIELOWSKI, Rebecca, DEITRICH, Lisa, POLLARD, Jennifer, GOKLEN, Kent, GAILLIOT, Francis

Volltext bestellen

Processes for isolation and purification of enfumafungin von DIETRICH LISA M, CHMIELOWSKI REBECCA A, GOKLEN KENT, POLLARD JENNIFER M, GAILLIOT FRANCIS P

Volltext bestellen

Enfumanginin saflaştırılması ve saflaştırma için işlemler von P. FRANCIS, GAILLIOT, KENT, GOKLEN, M. LISA, DEITRICH, A. REBECCA, CHMIELOWSKI, M. JENNIFER, POLLARD

Volltext bestellen